Real-world data studies in oncology: analysis of the Russian publications

Author:

Achikyan V. F.1ORCID,Kurylev A. A.2ORCID,Kolbin A. S.3ORCID

Affiliation:

1. First St. Petersburg State Medical University named after Academician I. P. Pavlov

2. First St. Petersburg State Medical University named after Academician I. P. Pavlov; National Medical Research Center of Oncology named after N. N. Petrov

3. First St. Petersburg State Medical University named after Academician I. P. Pavlov; St. Petersburg State University

Abstract

Background. Real-world data studies are an important source of knowledge on malignant tumors and their treatment. This knowledge is a tool for making decisions by health care professionals and patients. Regarding this, authors conducted literature search to identify real-world data studies published in the Russian scientific journals.Objective. The study aim was finding and analyzing publications on real-world evidence studies in oncology therapeutic area.Materials and methods. Full-text articles published in the Russian peer-reviewed medical scientific journals of 2022 and 2023 were systematically relieved and analyzed.Results. 119 publications were selected. The following types of study data were identified: 1) data on patients management practice; 2) survival and other oncology outcomes regardless of treatment approach; 3) survival and other oncology outcomes depending on treatment approach; 4) efficacy of a concrete therapy; 5) treatment safety (toxicity) data; 6) clinical and demographic prognostic factors; 7) tumor (morphological, molecular and genetic) prognostic factors; 8) tumor characteristics (morphological, molecular and genetic) regardless of their prognostic significance; 9) oncology disease characteristic (e. g., comorbidities) regardless of its prognostic significance. The most common types of study data were the following: clinical and demographic prognostic factors — 24 studies; tumor (morphological, molecular and genetic) prognostic factors — 36 studies; tumor characteristics (morphological, molecular and genetic) regardless of their prognostic significance — 38 studies.Conclusion. The modern real-world data studies in oncology therapeutic area are a very important source of knowledge on malignant tumors and their treatment.

Publisher

Publishing House OKI

Reference122 articles.

1. Zhuravkov AA, Moiseenko FV, Kolbin AS, Moiseenko VM. Research into actual clinical practice in oncology: trend or necessity? Practical oncology. 2023;24(1):59-69. (In Russ.). https://www.doi.org/10.31917/2401059.

2. Real-world clinical research. Updated recommendations for 2023. / under the general editorship of Kolbin A. S. — M .: OKI Publishing House, 2023. — 222 p. : ill. ISBN 978-5-907715-17-2. (In Russ.). https://izdat-oki.ru/issledovaniya-realnoj-klinicheskoj-praktikiobnovlyonnyerekomendacii-2023-goda

3. Decision of the Council of the Eurasian Economic Commission dated March 17, 2022 No. 36 “On amendments to the Rules for registration and examination of medicinal products for medical use.”. (In Russ.).

4. Fridman MV, Levin LF, Leonova ТA, et al. Clinical and Morphological Characteristics of Patients with Brain Metas-tases of Papillary Thyroid Carcinoma. Voprosy Onkologii. 2023;69(6):1065−1072 (In Russ.). doi: 10.37469/0507-3758-2023-69-61065-1072.

5. Agaeva A, Gromov D, Chemakina O, et al. Impact of surrogate molecular biological subtype on breast cancer survival: indepth epidemiological analysis based on the Archangelsk regional cancer registry data. Voprosy Onkologii, 2023;69(4):639–647. (In Russ.). doi: 10.37469/0507-3758-2023-69-4-639-647.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3